Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
4-?(6-?Nitro-?3-?pyridinyl)?-?1-?nitroso-piperazine is an intermediate used in the synthesis of Palbociclib-d4 (P139901), which is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.